Once-Daily Tacrolimus Extended-Release Formulation: 1 Year after Conversion in Stable Pediatric Kidney Transplant Recipients

Once-Daily Tacrolimus Extended-Release Formulation: 1 Year after Conversion in Stable Pediatric Kidney Transplant Recipients

It is speculated that a once-daily dosage of immunosuppression can increase adherence and thereby graft survival. Until now, there have been no studies on once-daily use of Tacrolimus extended-release formulation (TAC-ER) in children following pediatric kidney transplantation. In 11 stable pediatric...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lars Pape, Nele Heidotting, Thurid Ahlenstiel
Format:	Article
Language:	English
Published:	Wiley 2011-01-01
Series:	International Journal of Nephrology
Online Access:	http://dx.doi.org/10.4061/2011/126251
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A single‐center, open‐label, randomized cross‐over study to evaluate the pharmacokinetics and bioavailability of once‐daily prolonged‐release formulations of tacrolimus in de novo liver transplant recipients
by: Uta Herden, et al.
Published: (2021-12-01)

Personalized dosing protocol for extended-release tacrolimus in kidney transplant recipients in the early postoperative period
by: A. V. Shabunin, et al.
Published: (2023-04-01)

Tacrolimus to belatacept conversion in proteinuric kidney transplant recipients
by: Orhan Efe, et al.
Published: (2024-12-01)

Conversion from Extended-Dose-Release Tacrolimus to Melt-Dose Tacrolimus in High Metabolizer Patients: Is the New Formulation of LPCT the Best Option for High Metabolizer Kidney Transplanted Patients?
by: Paolo Carta, et al.
Published: (2020-05-01)

Twice-Daily versus Once-Daily Pramipexole Extended Release Dosage Regimens in Parkinson’s Disease
by: Ji Young Yun, et al.
Published: (2017-01-01)

Extended Efficacy of Once-Daily Atomoxetine in ADHD
by: J Gordon Millichap
Published: (2004-07-01)

Clinical results of and prospects for the use of controlled-release antiepileptic drugs: a new once-daily levetiracetam formulation
by: P. N. Vlasov
Published: (2017-11-01)

Effect of tacrolimus formulation on neurocognition in older kidney transplant recipients: A randomized controlled trial
by: Hadia Lala Gul, et al.
Published: (2025-09-01)

Pilot Analysis of Late Conversion to Belatacept in Kidney Transplant Recipients for Biopsy-Proven Chronic Tacrolimus Toxicity
by: Shruti Gupta, et al.
Published: (2018-01-01)

Tremors and Health-Related Quality of Life in Liver Transplant Recipients: Post-hoc Analysis of a Multicenter, Randomized, Controlled Trial Comparing a Life Cycle Pharma-Tacrolimus Regimen and Extended-Release Tacrolimus Regimen
by: M. B. Mulder, et al.
Published: (2025-04-01)

WCN24-2548 SHORT-TERM OUTCOMES WITH NO TAPERING TACROLIMUS TO BELATACEPT CONVERSION IN RENAL TRANSPLANT RECIPIENTS (RTRs)
by: Adela Mattiazzi, et al.
Published: (2024-04-01)

Patiromer Does Not Alter Tacrolimus Pharmacokinetics in Kidney Transplant Recipients When Administered Three Hours Post–Tacrolimus
by: Ole Martin Drevland, MSc, et al.
Published: (2024-12-01)

Treatment of Acute Tacrolimus Toxicity with Phenytoin in Solid Organ Transplant Recipients
by: Arin S. Jantz, et al.
Published: (2013-01-01)

Age-Related Differences in Rejection Rates, Infections, and Tacrolimus Exposure in Pediatric Kidney Transplant Recipients in the CERTAIN Registry
by: Maral Baghai Arassi, et al.
Published: (2024-11-01)

Assessing drug-drug interactions of Tacrolimus with Fluconazole and/or Verapamil and developing the predictive model for Tacrolimus concentrations in kidney transplant recipients
by: Mingkwan Na Takuathung, et al.
Published: (2025-06-01)

Complete regression of generalized plasmacytoma of lymph nodes in a liver transplant recipient during the conversion of immunosuppressive therapy from tacrolimus to everolimus
by: V. E. Syutkin, et al.
Published: (2021-09-01)

WCN24-1499 TACROLIMUS-INDUCED HYPOMAGNESEMIA IN A KIDNEY TRANSPLANT RECIPIENT
by: Wanprapit Noree, et al.
Published: (2024-04-01)

The association between serum tacrolimus concentrations and BK viruria in kidney transplant recipients
by: Napatsorn Kraivisitkul, et al.
Published: (2025-01-01)

Population dynamics analysis of the interaction between tacrolimus and voriconazole in renal transplant recipients
by: Zhi-Hua Sun, et al.
Published: (2025-01-01)

CONVERSION TO TACROLIMUS IN PATIENTS WITH LATE ACUTE AND CHRONIC REJECTION OF TRANSPLANTED KIDNEY
by: E. S. Stolyarevich, et al.
Published: (2011-06-01)

Intrapatient tacrolimus variability is associated with medical nonadherence among pediatric kidney transplant recipients
by: Tara B. Gavcovich, et al.
Published: (2025-03-01)

An equation for tacrolimus daily dose calculation in renal transplant patients - simple and cost saving?
by: Rančić Nemanja, et al.
Published: (2018-01-01)

Optimized tacrolimus dosing strategy in kidney transplant recipients receiving nirmatrelvir-ritonavir for COVID-19
by: Han Yan, et al.
Published: (2025-01-01)

HEMOFILTRATION AND COUPLED PLASMA FILTRATION ADSORPTION IMPACT ON TACROLIMUS BLOOD CONCENTRATION IN RENAL TRANSPLANT RECIPIENTS
by: A.V. Vatazin, et al.
Published: (2014-05-01)

A rare but important adverse effect of tacrolimus in a heart transplant recipient: diabetic ketoacidosis
by: Zeynelabidin Öztürk, et al.
Published: (2015-10-01)

P-117 CONTINUOUS INTRAVENOUS TACROLIMUS FOR LIVER TRANSPLANT RECIPIENTS: IMPLEMENTATION STRATEGY AND CLINICAL OUTCOMES
by: CAMILO ANDRES TORRES LONDOÑO, et al.
Published: (2024-12-01)

Tacrolimus Toxicity in Two Renal Transplant Recipients Treated With Nirmatrelvir/Ritonavir: A Case Series
by: Meaghan Coyne, et al.
Published: (2023-03-01)

Plasma Versus Whole Blood Tacrolimus Concentrations and Health-Related Quality of Life in Kidney Transplant Recipients
by: Svea Nolte, et al.
Published: (2025-04-01)

Tacrolimus Aggravated Tube Feeding Syndrome with Acute Renal Failure in a Pediatric Liver Transplant Recipient
by: R. Kula, et al.
Published: (2017-01-01)

Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety.
by: Catherine G Derington, et al.
Published: (2020-01-01)

Pharmacokinetics of Different Tacrolimus Formulations in the Early Post-Liver Transplant Period: A Scoping Review
by: Paloma Barriga-Rodríguez, et al.
Published: (2025-05-01)

WCN25-2900 CYP3A5 POLYMORPHISM AND TACROLIMUS CONCENTRATION IN INDIAN RENAL TRANSPLANT RECIPIENTS
by: Shreyas Akki, et al.
Published: (2025-02-01)

Fatal Lactic Acidosis in a Kidney Transplant Recipient on Combination Antiretroviral Therapy after Initiation of Tacrolimus Therapy
by: Michael V. Holmes, et al.
Published: (2011-01-01)

Once-Daily Aminoglycoside Dosing: A New Look at an Old Drug
by: JM Conly, et al.
Published: (1994-01-01)

Once-daily dosage lamivudine another ARV first for Cipla Medpro
by: Editorial Office
Published: (2008-02-01)

Medication adherence and outcomes after paediatric kidney transplantation: results from a telemedicine-based, multimodal aftercare approach
by: Sinem Karaterzi, et al.
Published: (2025-06-01)

Impact of CYP3A4 and ABCB1 genetic variants on tacrolimus dosing in Greek kidney transplant recipients
by: Anna Tsironi, et al.
Published: (2025-03-01)

Donor and recipient genetic variants in drug metabolizing enzymes and transporters affect early tacrolimus pharmacokinetics after liver transplantation
by: Alexandra D. Ladd, et al.
Published: (2025-07-01)

Tacrolimus dosing in liver transplant recipients using phenotypic personalized medicine: A phase 2 randomized clinical trial
by: Jeffrey Khong, et al.
Published: (2025-05-01)

Relevance of Tacrolimus Trough Concentration and Hepatitis E virus Genetic Changes in Kidney Transplant Recipients With Chronic Hepatitis E
by: Nancy León-Janampa, et al.
Published: (2024-05-01)